Joseph R. Moskal

Corporate Officer/Principal at Northwestern University

73 year

Consumer Services

Health Technology

Profile

Joseph R.
Moskal was the founder of Naurex, Inc. (founded in 2006) and Aptinyx, Inc. (founded in 2015), where he held the title of Chief Scientific Officer.
He is currently the Director-Falk Center for Molecular Therapeutics at Northwestern University since 2013.
Previously, he worked as the Director-Neurosurgery Laboratories at Albert Einstein College of Medicine, Inc. Dr. Moskal completed his undergraduate and doctorate degrees at the University of Notre Dame.

Joseph R. Moskal active positions

Companies	Position	Start
Northwestern University Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses	Corporate Officer/Principal	-

All active positions of Joseph R. Moskal

Former positions of Joseph R. Moskal

Companies	Position	End
Albert Einstein College of Medicine, Inc.	Corporate Officer/Principal	-
APTINYX	Founder	-
Naurex, Inc. Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL.	Founder	-

See the detail of Joseph R. Moskal's experience

Training of Joseph R. Moskal

University of Notre Dame

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Joseph R. Moskal's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
APTINYX	Health Technology

Private companies	1
Naurex, Inc. Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL.	Health Technology